At the news
? NEUTRALIMPACT 3/10 CLUSTER filed Nov 6, 2026 at 17:11 ET
Two HCA executives (EVP/COO Foster and EVP/Chief Clinical Officer Schlosser) sold a combined ~$1.43M in open-market shares this week, with Foster also exercising options and surrendering shares for tax withholding. The sales follow HCA's Q3 earnings (reported Oct 27) and a $1.95B debt issuance (Nov 5), but the open-market sales are small relative to HCA's market cap (estimated ~$130B), making them routine portfolio adjustments rather than a material signal.
- EVP/COO Foster sold ~$839K in open-market shares on Nov 6 (no 10b5-1 plan)
- EVP/Chief Clinical Officer Schlosser sold ~$594K in open-market shares on Nov 4 (no 10b5-1 plan)
- Foster also exercised 35,880 options at $145.24/share and surrendered 20,309 shares for tax withholding on Nov 4
- Total open-market sales by both executives: ~$1.43M, well under 0.1% of HCA's estimated $130B market cap
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access